Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the International Neuropsychological Society

• Publication date

  2008-02-18

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1017/S1355617708080570PMID 18282319PMCID PMC3138071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual

  2010cited by this paper
• Theory of mind and schizophrenia.

  2009cited by this paper
• Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

  2007cited by this paper
• Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.

  2007influential reference
• Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

  2006influential reference
• A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis.

  2006cited by this paper
• Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis.

  2005influential reference
• Focus on protein kinase A and protein kinase C, critical components of signal transduction system, in mood disorders and suicide.

  2005cited by this paper
• A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

  2005cited by this paper
• A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

  2005cited by this paper
• Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia.

  2005cited by this paper
• Identification of separable cognitive factors in schizophrenia.

  2004cited by this paper
• Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia.

  2004influential reference
• NIMH-MATRICS survey on assessment of neurocognition in schizophrenia.

  2004cited by this paper
• Short- and Long-Term Spatial Delayed Response Performance Across the Lifespan

  2004cited by this paper
• A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity.

  2004cited by this paper
• The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery.

  2004influential reference
• Pretreatment and longitudinal studies of neuropsychological deficits in antipsychotic-naïve patients with schizophrenia.

  2004influential reference
• SOCIAL COGNITION AND NEUROCOGNITIVE DEFICITS IN SCHIZOPHRENIA

  2003cited by this paper
• The neuropsychological study of schizophrenia: A methodological perspective.

  2003cited by this paper
• Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.

  2003influential reference
• Is emotion processing a predictor of functional outcome in schizophrenia?

  2003cited by this paper
• General and specific cognitive deficits in schizophrenia.

  2003cited by this paper
• The joint WAIS-III and WMS-III factor structure: development and cross-validation of a six-factor model of cognitive functioning.

  2003cited by this paper
• The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone.

  2002influential reference
• Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.

  2002cited by this paper
• Short-Term Cognitive Improvement in Schizophrenics Treated with Typical and Atypical Neuroleptics

  2002cited by this paper
• Social cognition and schizophrenia.

  2001cited by this paper
• Neuropsychological differences among empirically derived clinical subtypes of schizophrenia.

  2001cited by this paper
• Practice-related improvement in information processing with novel antipsychotic treatment.

  2000cited by this paper
• Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

  2000influential reference
• Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

  2000cited by this paper
• Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia.

  1999cited by this paper
• California Verbal Learning Test practice effects in a schizophrenia sample.

  1999cited by this paper
• Evaluating the use of exploratory factor analysis in psychological research.

  1999cited by this paper
• The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.

  1999cited by this paper
• Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.

  1999influential reference
• Confirmatory factor analysis of the WAIS-R in patients with schizophrenia.

  1998influential reference
• Moderator variables of executive functioning in schizophrenia: meta-analytic findings.

  1998cited by this paper
• Data analysis in social psychology.

  1998cited by this paper
• Exploratory factor analysis: its role in item analysis.

  1997cited by this paper
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• What are the functional consequences of neurocognitive deficits in schizophrenia?

  1996cited by this paper
• The nature of learning and memory impairments in schizophrenia

  1995cited by this paper
• The neuropsychological signature of schizophrenia: generalized or differential deficit?

  1994cited by this paper
• Stability of neurological signs with clozapine treatment.

  1994cited by this paper
• Forms of memory failure in schizophrenia.

  1992cited by this paper
• Neuropsychological function in schizophrenia. Selective impairment in memory and learning.

  1991influential reference
• Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients.

  1990cited by this paper
• Component Analysis versus Common Factor Analysis: Some Further Observations.

  1990cited by this paper
• Component Analysis versus Common Factor Analysis: A Case of Disputed Authorship.

  1990influential reference
• Common Factor Analysis versus Component Analysis: Some Well and Little Known Facts.

  1990cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Latent variable models: an introduction to factor, path, and structural analysis

  1986cited by this paper
• WAIS-R manual : Wechsler adult intelligence scale-revised

  1981cited by this paper
• Handbook of Social Psychology.

  1955cited by this paper

• Mobile cognitive remote assessment of schizophrenia: a global multi-site pilot study

  2025cites this paper
• Neural fingerprints of data driven cognitive subtypes across the psychosis spectrum: a B-SNIP study

  2025cites this paper
• The role of metacognition and social cognition in childhood trauma effecting on prognosis: 1-year follow-up study in patients with first-episode schizophrenia

  2025cites this paper
• Relationship Between Illness Duration and Social Cognitive Abilities in Schizophrenia Spectrum Disorder

  2025cites this paper
• Social cognition across the schizophrenia–bipolar disorder spectrum

  2024cites this paper
• Retinal electrophysiological alterations are associated with cognition in early course psychosis.

  2024cites this paper
• Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities

  2024cites this paper
• Lesion network guided delta frequency neuromodulation improves cognition in patients with psychosis spectrum disorders: A pilot study.

  2023cites this paper
• Patterns of Impaired Neurocognitive Performance on the Global Neuropsychological Assessment, and Their Brain Structural Correlates in Recent-onset and Chronic Schizophrenia

  2023cites this paper
• Bifactor model of cognition in schizophrenia: Evidence for general and specific abilities.

  2021cites this paper
• Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders.

  2021cites this paper
• Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder.

  2020cites this paper
• Social cognition in patients with first episode of psychosis in remission

  2020cites this paper
• Characterization of social cognitive deficits on the schizophrenia-bipolar disorder spectrum: An overview of current evidence

  2019cites this paper
• Cognitive impairments in individuals at clinical high-risk for psychosis:relationships to clinical symptoms and functioning and prediction of functional outcome

  2019influential citation
• The brief assessment of cognition in affective disorders: Normative data for the Italian population.

  2019cites this paper
• Validation of the tablet-administered Brief Assessment of Cognition (BAC App).

  2017influential citation
• Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis

  2017cites this paper
• A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).

  2017cites this paper
• No cognitive‐enhancing effect of GLP‐1 receptor agonism in antipsychotic‐treated, obese patients with schizophrenia

  2017cites this paper
• Do Different Versions of the Continuous Performance Test Measure the Same Constructs

  2016cites this paper
• Cognitive functioning and insight in schizophrenia and in schizoaffective disorder Funzionamento cognitivo e insight nella schizofrenia e nel disturbo schizoaffettivo

  2016cites this paper
• Deficits in social cognition in first episode psychosis: A review of the literature.

  2016influential citation
• Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.

  2016influential citation
• Der Einfluss des kognitiven Status schizophren Erkrankter auf Zielkriterien der Psychoedukation

  2015cites this paper
• An abbreviated version of the brief assessment of cognition in schizophrenia (BACS)

  2015cites this paper
• Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia

  2014cites this paper
• Cognitive impairments in psychotic disorders: common mechanisms and measurement

  2014cites this paper
• Neurobiology of Cognitive Remediation Therapy for Schizophrenia: A Systematic Review

  2014cites this paper
• Development of Abbreviated Eight-Item Form of the Penn Verbal Reasoning Test

  2014cites this paper
• Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery.

  2014cites this paper
• The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls.

  2014cites this paper
• Social cognition and neurocognitive deficits in first-episode schizophrenia.

  2014cites this paper
• Cognitive functioning and insight in schizophrenia and in schizoaffective disorder.

  2014cites this paper
• Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

  2014influential citation
• Toward a more parsimonious assessment of neurocognition in schizophrenia: a 10-minute assessment tool.

  2014cites this paper
• Thinking and Acting Beyond the Positive : The Role of the Cognitive and Negative Symptoms in Schizophrenia

  2014cites this paper
• Hiperactivacion cortical y deterioro cognitivo en esquizofrenia

  2014cites this paper
• Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?

  2014cites this paper
• Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5.

  2013cites this paper
• Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.

  2013cites this paper
• Sequential processing deficits in schizophrenia: relationship to neuropsychology and genetics.

  2013cites this paper
• Investigations Of The Determinants of Functional Outcomes In Schizophrenia: Cross-sectional And Longitudinal Examinations Of The Role Of Negative Symptoms

  2013cites this paper
• Brief assessment of cognition in schizophrenia: normative data in an English-speaking ethnic Chinese sample.

  2013cites this paper
• Social and neuro-cognition as distinct cognitive factors in schizophrenia: a systematic review.

  2013influential citation
• Cognitive effects of six months of treatment with quetiapine in antipsychotic-naïve first-episode schizophrenia.

  2011cites this paper
• Validation of the German Version of the Brief Assessment of Cognition in Schizophrenia (BACS) – Preliminary Results

  2011cites this paper
• A brief cognitive assessment tool for schizophrenia: construction of a tool for clinicians.

  2011cites this paper
• Cognition in First Episode Schizophrenia: Core Deficits and Effets of Antipsychotics

  2010cites this paper
• Effect of second-generation antipsychotics on cognition: current issues and future challenges

  2010cites this paper
• Neurocognition in early-onset schizophrenia and schizoaffective disorders.

  2010cites this paper
• Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S).

  2010cites this paper
• Current awareness in human psychopharmacology.

  2009cites this paper
• CURRICULUM VITAE PERSONAL INFORMATION : Name:

  2009cites this paper
• A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia

  2009influential citation
• Current awareness in human psychopharmacology

  2008cites this paper
• Implementation considerations for multisite clinical trials with cognitive neuroscience tasks.

  2007cites this paper